Physician
Hematology
Dr. Robert A. Kyle, MD
|
|
Give Review
Doctor Robert A. Kyle, MD works in the field of Hematology. He attended Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19 in research and 29 in primary care medicine He has 33 awards "Alumnus of the Year", "Erwin Neter Lecturer and Awardee", "Inaugural Recipient for Multiple Myeloma", "Lifetime Achievement Distinguished Lecturer", "Wallace Coulter Lifetime Achievement Award", "David Karnofsky Award and Lecture", "Joseph Michaeli Award", "Distinguished Alumni Award", "Celgene Career Achievement Award", "Lifetime Achievement Award", "Honorary member", "Honorary Doctor of Letters", "Research Career Achievement Award", "Honorary Title "Socius Honores Causa"", "Medallion Medal", "First Mayo Fellows Association Distinguished Professor", "Honorary Doctorate Degree in Medicine", "Robert A. Kyle Award", "Karis Award", "Sioux Award", "Distinguished Clinician Award", "Distinguished Lecturer", "Henry S. Plummer Distinguished Internist Award", "Waldenstrom Award", "Teacher of the Year in Internal Medicine", "Golden Service Award", "Distinguished Topical Philatelist", "Myrtle Watt Award for Medical Philately Journalism", "Certificate of Appreciation", "John Brain Medal and Plaque for Philatelic Congress", "Phi Beta Kappa", "Phi Theta Kappa" and "Pi Kappa Epsilon". Robert Kyle is a published physician as well. He has 100 publications published. The latest was: Treatment of Multiple Myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group.
Publications
- The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma.
- Outcomes of primary refractory multiple myeloma and the impact of novel therapies.
- Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.
- Evidence Against Routine Testing of Patients With Functional Gastrointestinal Disorders for Celiac Disease: A Population-based Study.
- Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma.
- Soluble suppression of tumorigenicity 2 (sST2), but not Galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and Tropo...
- Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis.
- Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritis.
- Clinical Course and Prognosis of Non-Secretory Multiple Myeloma.
- Diagnosis of monoclonal gammopathy of renal significance.
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.
- Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias.
- Impact of Pre-transplant Therapy and Depth of Disease Response prior to Autologous Transplantation for Multiple Myeloma.
- Protein electrophoresis and immunofixation for the diagnosis of monoclonal gammopathies.
- Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort study.
- Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma.
- Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexist.
- Treatment recommendations for patients with Waldenström's Macroglobulinemia (WM) and related disorders: consensus from the Seventh International Workshop on WM.
- Trends in survival of patients with primary plasma cell leukemia: a population based analysis.
- Yield of Noncardiac Biopsy for the Diagnosis of Transthyretin Cardiac Amyloidosis.
- Imaging findings in 22 cases of Schnitzler syndrome: characteristic para-articular osteosclerosis, and the "hot knees" sign differential diagnosis.
- High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis.
- Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy.
- An overview of the progress in the treatment of multiple myeloma.
- A structurally distinct human mycoplasma protein that generically blocks antigen-antibody union.
- Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant.
- Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12â482 persons from the National Health and Nutritional Examination Survey.
- Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
- Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantation.
- How I treat monoclonal gammopathy of renal significance (MGRS).
- Long term response to lenalidomide in patients with newly diagnosed multiple myeloma.
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.
- Haematological cancer: Treatment of smoldering multiple myeloma.
- Smoldering multiple myeloma requiring treatment: time for a new definition?
- Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategies.
- Unusual myelomas: a review of IgD and IgE variants.
- Outcomes of patients with POEMS syndrome treated initially with radiation.
- Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
- Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.
- Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma.
- Treatment patterns and outcomes in elderly patients with multiple myeloma.
- High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma.
- Impact of Primary Molecular Cytogenetic Abnormalities and Risk of Progression in Smoldering Multiple Myeloma.
- Risk of Acute Leukemia and Myelodysplastic Syndromes in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS): a Population-Based Study of 17 315 Pat...
- Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myeloma.
- Implantable Cardioverter Defibrillators in Patients with Cardiac Amyloidosis.
- Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma.
- Elias James Corey--Nobel Prize for retrosynthetic analysis.
- Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS.
- Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.
- Urinary Albumin Excretion Patterns of Patients with Cast Nephropathy and Other Monoclonal Gammopathy-Related Kidney Diseases.
- Trends and outcomes of modern staging of solitary plasmacytoma of bone.
- Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies.
- Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics.
- Immunoglobulin D amyloidosis: a distinct entity.
- Bone microstructural changes revealed by HRpQCT imaging and elevated DKK1 and MIP-1? levels in patients with monoclonal gammopathy of undetermined significance.
- Long-Term Biologic Variation of Serum Protein Electrophoresis M-spike, Urine M-spike, and Monoclonal Serum Free Light Chain Quantification: Implications for Monitoring...
- Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease.
- The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome.
- Diagnosis of smoldering multiple myeloma.
- Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma.
- Albert sabin--conqueror of poliomyelitis.
- Trends in allogeneic stem cell transplantation for multiple myeloma: a Center for International Blood and Marrow Transplant Research (CIBMTR) analysis.
- Frederick Soddy--pioneer in radioactivity.
- Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.
- Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
- Effect of Obesity on Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
- Role of maintenance therapy after autologous stem cell transplant for multiple myeloma: lessons for cancer therapy.
- Aleksandr Prokhorov--lasers and masers.
- J. Craig Venter--The human genome project.
- High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa.
- From myeloma precursor disease to multiple myeloma: new diagnostic concepts and opportunities for early intervention.
- Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis.
- Susumu Tonegawa--Japan's first Nobel laureate in physiology or medicine.
- IgM Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Waldenström's Macroglobulinemia (SWM).
- Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score.
- Bernard Kouchner--founder of doctors without borders.
- Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features.
- Specificity of serum and urine protein electrophoresis for the diagnosis of monoclonal gammopathies.
- Outcome of Patients With IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Retrospective CIBMTR Study.
- Abbie Lathrop, the "mouse woman of Granby": rodent fancier and accidental genetics pioneer.
- Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune mo...
- Robert Arthur Kyle, MD: a conversation with the editor.
- Walter Clement Noel—first patient described with sickle cell disease.
- Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing d...
- Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma.
- Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications.
- Stamp vignette on medical science. Francis S. Collins--Human Genome Project.
- Morbidity and mortality among older individuals with undiagnosed celiac disease.
- Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma.
- Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines.
- Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women.
- Stamp vignette on medical science. Robert F. Curl Jr-Nobel Laureate in Chemistry.
- Edward L. Trudeau--founder of a sanatorium for treatment of tuberculosis.
- Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie.
- Retraction: Naturally occurring human IgM antibody that binds B7-DC and potentiates T cell stimulation by dendritic cells.
- Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome.
- e-Stamp vignette on medical science. Ludwik Hirszfeld--Polish immunologist, microbiologist, and hematologist.
- Treatment of Multiple Myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group.
Schools
Northwestern Center Feinberg School of Medicine
Evanston Hospital
Mayo Foundation For Med Education and Research
New Eng Center Hospital
Doctors Specialties
- Hematology
Accepted Insurances
Awards
- Alumnus of the Year
- Erwin Neter Lecturer and Awardee
- Inaugural Recipient for Multiple Myeloma
- Lifetime Achievement Distinguished Lecturer
- Wallace Coulter Lifetime Achievement Award
- David Karnofsky Award and Lecture
- Joseph Michaeli Award
- Distinguished Alumni Award
- Celgene Career Achievement Award
- Lifetime Achievement Award
- Honorary member
- Honorary Doctor of Letters
- Research Career Achievement Award
- Honorary Title "Socius Honores Causa"
- Medallion Medal
- First Mayo Fellows Association Distinguished Professor
- Honorary Doctorate Degree in Medicine
- Robert A. Kyle Award
- Karis Award
- Sioux Award
- Distinguished Clinician Award
- Distinguished Lecturer
- Henry S. Plummer Distinguished Internist Award
- Waldenstrom Award
- Teacher of the Year in Internal Medicine
- Golden Service Award
- Distinguished Topical Philatelist
- Myrtle Watt Award for Medical Philately Journalism
- Certificate of Appreciation
- John Brain Medal and Plaque for Philatelic Congress
- Phi Beta Kappa
- Phi Theta Kappa
- Pi Kappa Epsilon
Education
-
Tufts Medical Center -
Mayo School of Graduate Medical Education -
University of Minnesota -
Northwestern University Feinberg School of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Similar Doctors
|
|
Dr. Mateusz Opyrchal, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francis K. Buadi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naseema Gangat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rafael Santana-Davila, MD |
|
|
Dr. Jennifer L. Herrick, MD |
|
|
Dr. Shernan G. Holtan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alla Keyzner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eapen K. Jacob, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kostandinos Sideras, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Dingli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wilson I. Gonsalves, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil E. Kay, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessemy D. Neiger, MD |
|
|
Dr. Shakila P. Khan, MD |
|
|
Dr. Jeremy C. Jones, MD |
|
|
Dr. Evidio Domingo Musibay, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Carrie M. Thompson, NP
This Doctor is OpenDoctor Recommended.
|